185 related articles for article (PubMed ID: 33541006)
1. [Advances in head and neck squamous cell cancer research based on radiomics].
Dong Y; Zhang A; Zhang J; Liu L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Feb; 35(2):181-184. PubMed ID: 33541006
[No Abstract] [Full Text] [Related]
2. Radiomics-based prediction of survival in patients with head and neck squamous cell carcinoma based on pre- and post-treatment
Liu Z; Cao Y; Diao W; Cheng Y; Jia Z; Peng X
Aging (Albany NY); 2020 Jul; 12(14):14593-14619. PubMed ID: 32674074
[TBL] [Abstract][Full Text] [Related]
3. A prediction model for degree of differentiation for resectable locally advanced esophageal squamous cell carcinoma based on CT images using radiomics and machine-learning.
Kawahara D; Murakami Y; Tani S; Nagata Y
Br J Radiol; 2021 Aug; 94(1124):20210525. PubMed ID: 34235955
[TBL] [Abstract][Full Text] [Related]
4. Construction of an enhanced computed tomography radiomics model for non-invasively predicting granzyme A in head and neck squamous cell carcinoma by machine learning.
Hang R; Bai G; Sun B; Xu P; Sun X; Yan G; Zhang W; Wang F
Eur Arch Otorhinolaryngol; 2023 Jul; 280(7):3353-3364. PubMed ID: 36920557
[TBL] [Abstract][Full Text] [Related]
5. Constrast-enhanced computed tomography radiomics predicts CD27 expression and clinical prognosis in head and neck squamous cell carcinoma.
Wang F; Zhang W; Chai Y; Wang H; Liu Z; He Y
Front Immunol; 2022; 13():1015436. PubMed ID: 36458007
[TBL] [Abstract][Full Text] [Related]
6. Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures.
Mes SW; van Velden FHP; Peltenburg B; Peeters CFW; Te Beest DE; van de Wiel MA; Mekke J; Mulder DC; Martens RM; Castelijns JA; Pameijer FA; de Bree R; Boellaard R; Leemans CR; Brakenhoff RH; de Graaf P
Eur Radiol; 2020 Nov; 30(11):6311-6321. PubMed ID: 32500196
[TBL] [Abstract][Full Text] [Related]
7. Radiomics and radiogenomics in head and neck squamous cell carcinoma: Potential contribution to patient management and challenges.
Bruixola G; Remacha E; Jiménez-Pastor A; Dualde D; Viala A; Montón JV; Ibarrola-Villava M; Alberich-Bayarri Á; Cervantes A
Cancer Treat Rev; 2021 Sep; 99():102263. PubMed ID: 34343892
[TBL] [Abstract][Full Text] [Related]
8. Quantitative US Delta Radiomics to Predict Radiation Response in Individuals with Head and Neck Squamous Cell Carcinoma.
Osapoetra LO; Dasgupta A; DiCenzo D; Fatima K; Quiaoit K; Saifuddin M; Karam I; Poon I; Husain Z; Tran WT; Sannachi L; Czarnota GJ
Radiol Imaging Cancer; 2024 Mar; 6(2):e230029. PubMed ID: 38391311
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a Model Using Radiomics Features from an Apparent Diffusion Coefficient Map to Diagnose Local Tumor Recurrence in Patients Treated for Head and Neck Squamous Cell Carcinoma.
Kim M; Lee JH; Joo L; Jeong B; Kim S; Ham S; Yun J; Kim N; Chung SR; Choi YJ; Baek JH; Lee JY; Kim JH
Korean J Radiol; 2022 Nov; 23(11):1078-1088. PubMed ID: 36126954
[TBL] [Abstract][Full Text] [Related]
10. Radiomic biomarkers for head and neck squamous cell carcinoma.
Tanadini-Lang S; Balermpas P; Guckenberger M; Pavic M; Riesterer O; Vuong D; Bogowicz M
Strahlenther Onkol; 2020 Oct; 196(10):868-878. PubMed ID: 32495038
[TBL] [Abstract][Full Text] [Related]
11. Dual-energy CT-based radiomics nomogram in predicting histological differentiation of head and neck squamous carcinoma: a multicenter study.
Li Z; Liu Z; Guo Y; Wang S; Qu X; Li Y; Pan Y; Zhang L; Su D; Yang Q; Tao X; Yue Q; Xian J
Neuroradiology; 2022 Feb; 64(2):361-369. PubMed ID: 34860278
[TBL] [Abstract][Full Text] [Related]
12. A computed tomography-based radiomics signature for predicting expression of programmed death ligand 1 in head and neck squamous cell carcinoma.
Zheng YM; Yuan MG; Zhou RQ; Hou F; Zhan JF; Liu ND; Hao DP; Dong C
Eur Radiol; 2022 Aug; 32(8):5362-5370. PubMed ID: 35298679
[TBL] [Abstract][Full Text] [Related]
13. Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status.
Ou D; Blanchard P; Rosellini S; Levy A; Nguyen F; Leijenaar RTH; Garberis I; Gorphe P; Bidault F; Ferté C; Robert C; Casiraghi O; Scoazec JY; Lambin P; Temam S; Deutsch E; Tao Y
Oral Oncol; 2017 Aug; 71():150-155. PubMed ID: 28688683
[TBL] [Abstract][Full Text] [Related]
14. A multi-objective radiomics model for the prediction of locoregional recurrence in head and neck squamous cell cancer.
Wang K; Zhou Z; Wang R; Chen L; Zhang Q; Sher D; Wang J
Med Phys; 2020 Oct; 47(10):5392-5400. PubMed ID: 32657426
[TBL] [Abstract][Full Text] [Related]
15. Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy.
Tang S; Ou J; Liu J; Wu YP; Wu CQ; Chen TW; Zhang XM; Li R; Tang MJ; Yang LQ; Tan BG; Lu FL; Hu J
Cancer Imaging; 2021 May; 21(1):38. PubMed ID: 34039403
[TBL] [Abstract][Full Text] [Related]
16. FLT PET Radiomics for Response Prediction to Chemoradiation Therapy in Head and Neck Squamous Cell Cancer.
Ulrich EJ; Menda Y; Boles Ponto LL; Anderson CM; Smith BJ; Sunderland JJ; Graham MM; Buatti JM; Beichel RR
Tomography; 2019 Mar; 5(1):161-169. PubMed ID: 30854454
[TBL] [Abstract][Full Text] [Related]
17. Quantitative ultrasound radiomics in predicting recurrence for patients with node-positive head-neck squamous cell carcinoma treated with radical radiotherapy.
Dasgupta A; Fatima K; DiCenzo D; Bhardwaj D; Quiaoit K; Saifuddin M; Karam I; Poon I; Husain Z; Tran WT; Sannachi L; Czarnota GJ
Cancer Med; 2021 Apr; 10(8):2579-2589. PubMed ID: 33314716
[TBL] [Abstract][Full Text] [Related]
18. A CT-based radiomics signature for preoperative discrimination between high and low expression of programmed death ligand 1 in head and neck squamous cell carcinoma.
Zheng YM; Zhan JF; Yuan MG; Hou F; Jiang G; Wu ZJ; Dong C
Eur J Radiol; 2022 Jan; 146():110093. PubMed ID: 34890937
[TBL] [Abstract][Full Text] [Related]
19. Preliminary Computed Tomography Radiomics Model for Predicting Pretreatment CD8+ T-Cell Infiltration Status for Primary Head and Neck Squamous Cell Carcinoma.
Wang CY; Ginat DT
J Comput Assist Tomogr; 2021 Jul-Aug 01; 45(4):629-636. PubMed ID: 34519454
[TBL] [Abstract][Full Text] [Related]
20. Utility of adding Radiomics to clinical features in predicting the outcomes of radiotherapy for head and neck cancer using machine learning.
Gangil T; Sharan K; Rao BD; Palanisamy K; Chakrabarti B; Kadavigere R
PLoS One; 2022; 17(12):e0277168. PubMed ID: 36520945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
